BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/13/2025 2:05:21 PM | Browse: 90 | Download: 184
Publication Name World Journal of Gastroenterology
Manuscript ID 100785
Country China
Received
2024-08-27 08:35
Peer-Review Started
2024-08-29 00:18
To Make the First Decision
Return for Revision
2024-11-30 06:56
Revised
2024-12-13 14:08
Second Decision
2025-02-13 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-02-13 03:25
Articles in Press
2025-02-13 03:25
Publication Fee Transferred
2024-12-17 08:48
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-02-27 08:37
Publish the Manuscript Online
2025-03-13 10:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Ya-Ru Niu, Mi-dan Xiang, Wen-Wei Yang, Yu-Ting Fang, Hai-Li Qian and Yong-Kun Sun
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82072756
Beijing Xisike Clinical Oncology Research Foundation Y-HR2019-0285
Corresponding Author Yong-Kun Sun, PhD, Chief Doctor, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. hsunyk@cicams.ac.cn
Key Words Colorectal cancer; Chemotherapy resistance; Glycolysis; SIRT1; NAD+
Core Tip SIRT1, a NAD+-dependent deacetylase, has demonstrated anti-tumor effects in numerous studies. However, the role of SIRT1 in regulating oxaliplatin resistance remains unclear. This study found that SIRT1 expression is downregulated in oxaliplatin-resistant colorectal cancer (CRC) cell. Enhancing SIRT1 expression reverses this resistance. Mechanistically, DNA damage-induced PARP activation inhibits SIRT1 expression. The inhibition of SIRT1 promotes drug resistance in CRC cells by enhancing glycolysis. These findings highlight the critical role of SIRT1 in oxaliplatin resistance and support the potential of combining SIRT1 agonists with oxaliplatin as a therapeutic strategy to overcome CRC resistance.
Publish Date 2025-03-13 10:10
Citation <p>Niu YR, Xiang MD, Yang WW, Fang YT, Qian HL, Sun YK. NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer. <i>World J Gastroenterol</i> 2025; 31(11): 100785</p>
URL https://www.wjgnet.com/1007-9327/full/v31/i11/100785.htm
DOI https://dx.doi.org/10.3748/wjg.v31.i11.100785
Full Article (PDF) WJG-31-100785-with-cover.pdf
The ARRIVE Guidelines 100785-The-ARRIVE-Guidelines.pdf
Manuscript File 100785_Auto_Edited_054456.docx
Answering Reviewers 100785-answering-reviewers.pdf
Audio Core Tip 100785-audio.mp3
Biostatistics Review Certificate 100785-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 100785-conflict-of-interest-statement.pdf
Copyright License Agreement 100785-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 100785-foundation-statement.pdf
Institutional Animal Care and Use Committee Approval Form or Document 100785-institutional-animal-care-and-use-committee-statement.pdf
Non-Native Speakers of English Editing Certificate 100785-non-native-speakers.pdf
Peer-review Report 100785-peer-reviews.pdf
Scientific Misconduct Check 100785-scientific-misconduct-check.png
Scientific Editor Work List 100785-scientific-editor-work-list.pdf
CrossCheck Report 100785-crosscheck-report.pdf